PATIENT INFORMATION · PRODUCT AND APPOINTMENT
Priligy information should help a reader identify the medicine and describe the problem they want assessed. Start with the ingredient and the patient leaflet, then use product comparisons to prepare questions about the actual pack and supply.
Identify the medicine before interpreting a claim
Priligy is a brand containing dapoxetine. The Irish HPRA product record identifies the 60 mg film-coated tablet and links its current professional information and patient leaflet. The record establishes details of that authorised product; it does not authenticate a different pack displayed by another website.
When comparing descriptions, record the full name, ingredient, strength, tablet form, manufacturer or licence holder and quantity. Do not treat a familiar brand spelling as the entire identification process. If a photograph and the written description show different strengths, ask for clarification instead of choosing whichever detail seems more plausible.
Describe the concern in your own words
The Priligy patient leaflet describes treatment of premature ejaculation in men aged 18–64. It is not a general sexual-performance supplement. The leaflet also asks patients to discuss other sexual problems, including erectile dysfunction, with their clinician.
For an appointment, note when the concern began, how often it occurs, whether the pattern has changed and what effect it has on wellbeing or relationships. Describe what feels difficult rather than fitting the experience into a phrase copied from an advertisement. If more than one concern is present, mention each of them.
This account is useful even when no medicine is eventually prescribed. It gives the consultation a clear starting point and helps avoid a conversation organised entirely around a product that happened to appear in search results.
Use a product comparison to make the questions specific
A reader looking at the Priligy product information and comparisons at ED Premium Choice can list the pack details that need confirmation before discussing a pharmacy offer. Keep the product description separate from claims about treatment benefit. A price comparison does not establish a diagnosis or prove that one strength is suitable for an individual.
Ask what the quoted amount includes, which product would actually be supplied and who answers dispensing questions. If the service includes a consultation, clarify whether its fee is payable even when treatment is not prescribed. A useful comparison preserves those conditions beside the headline price.
Our guide to checking the product behind a medicine name gives another example of why an ingredient claim and a supplied pack need separate evidence. The same discipline applies here without assuming that different medicines have the same uses or risks.
Bring a complete medication history
The patient leaflet highlights fainting, important medicine interactions and alcohol-related risk. Tell the clinician about antidepressants, other prescriptions, over-the-counter products and supplements, as well as previous fainting or relevant medical conditions. Do not stop an existing medicine simply to make a proposed product appear compatible.
A list of names is more useful than a statement that everything is “usual.” If you do not know a name, bring the packaging or the current dispensing record. Include recently stopped treatment and occasional products so that the clinician can decide which details matter.
Ask for the exact directions, what to do if an unwanted effect occurs, when the treatment will be reviewed and how to contact the service between visits. A written answer is easier to use than an assumption based on a tablet count.
Read the warning section as well as the benefit claim
The leaflet lists dizziness, headache and nausea as very common adverse effects. It calls for immediate medical advice after fainting, seizures or concerning mood changes. Read the full leaflet for the supplied product; a short web summary cannot cover every warning or interaction.
Keep a dated note of the questions resolved by the clinician and those still awaiting the pharmacist. That record helps a later review focus on actual experience and the supplied medicine, rather than a remembered advertisement.
Return to Drug Safety, Access and Regulatory Evidence for more on matching product claims to the records that support them.
To examine the research behind benefit claims, read our dapoxetine evidence guide, which keeps the comparator, patient outcomes and adverse effects visible together.
Editorial information, not individual diagnosis or prescribing advice. Product comparisons are not institutional endorsements of a medicine or supplier.
MEDICALLY REVIEWED BY
Jodi Segal, MD, MPH
Comparative effectiveness, drug safety and general internal medicine.